Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-27-049
- Assistance listing (CFDA)
- 93.846
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the s...
Related opportunities
- Research Program Award (R35 Clinical Trial Optional)National Institutes of HealthUp to $750K
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2029Up to $250K
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)Food and Drug Administration
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Nov 2028
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2026Up to $150K
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)National Institutes of Health